Want to see AU:BIT full AI Analyst Report?
Biotron (BIT) Stock Statistics & Valuation Metrics
Total Valuation
Biotron has a market cap or net worth of AUD 5.57M. The enterprise value is AUD 6.55M.
- Market Cap
- AUD 5.57M
- Enterprise Value
- AUD 6.55M
Share Statistics
Biotron has 2,785,205,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,785,205,000
- Owned by Insiders
- 10.21%
- Owned by Institutions
- ―
Financial Efficiency
Biotron ’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -49.02%.
- Return on Equity (ROE)
- -0.52
- Return on Assets (ROA)
- -0.41
- Return on Invested Capital (ROIC)
- -49.02%
- Return on Capital Employed (ROCE)
- -0.66
- Revenue Per Employee
- 0
- Profits Per Employee
- -379.58K
- Employee Count
- 4
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Biotron is -3.56. Biotron ’s PEG ratio is 0.01.
- PE Ratio
- -3.56
- PS Ratio
- 0.00
- PB Ratio
- 1.85
- Price to FCF
- -1.71
- Price to Operating Cash Flow
- -2.81
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Biotron had revenue of 0 and earned -1.52M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- -1,913
- Operating Income
- -1.93M
- Pretax Income
- -2.04M
- Net Income
- -1.52M
- EBITDA
- -1.93M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -1.92M and capital expenditures 0, giving a free cash flow of -1.92M billion.
- Operating Cash Flow
- -1.92M
- Free Cash Flow
- -1.92M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Biotron pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -58.55%
- Earnings Yield
- -28.10%
Stock Price Statistics
- Beta
- 1.04
- 52-Week Price Change
- -87.06%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Biotron upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Biotron as a current ratio of 1.94, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.94
- Quick Ratio
- 1.94
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.81
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Biotron has paid -525.87K in taxes.
- Income Tax
- -525.87K
- Effective Tax Rate
- 0.26
Enterprise Valuation
Biotron EV to EBITDA ratio is -0.90, with an EV/FCF ratio of -0.90.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.90
- EV to Free Cash Flow
- -0.90
- EV to Operating Cash Flow
- -0.90
Balance Sheet
Biotron has AUD 1.64M in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 1.64M billion.
- Cash & Marketable Securities
- AUD 1.64M
- Total Debt
- AUD 0.00
- Net Cash
- AUD 1.64M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Biotron is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -100.00%
Scores
- Smart Score
- 3
- AI Score
- 43